業(ye) 務谘詢
中國：
Email: marketing@boboandtiantian.com
業(ye) 務谘詢專(zhuan) 線：400-780-8018
（僅(jin) 限服務谘詢，其他事宜請撥打川沙總部電話）
川沙總部電話: +86 (21) 5859-1500
海外：
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
Despite progress in the treatment of T-cell acute lymphoblastic leukemia (T-ALL) has limited treatment options, particularly in the setting of relapsed/refractory disease. Researchers used SHMT1/2 inhibitor RZ-2994 to characterize the effect of inhibiting SHMT1/2 in T-ALL.
Loss of both SHMT1/2 is necessary for impaired growth and cell cycle arrest, with suppression of SHMT1/2 inhibiting leukemia progression. RZ-2994 also decreases leukemia burden in vivo. RZ-2994 was obtained from Medicilon.
Medicilon offers a full range of chemical services covering all phases of your project. Customers can work with us either through FFS or FTE.
Reference:
川沙總部
地址: 上海市浦東(dong) 新區川大路585號
郵編: 201299
電話: +86 (21) 5859-1500（總機）
傳(chuan) 真: +86 (21) 5859-6369
業(ye) 務谘詢
中國：
Email: marketing@medicilon.com
業(ye) 務谘詢專(zhuan) 線：400-780-8018
（僅(jin) 限服務谘詢，其他事宜請撥打川沙
總部電話）
海外：
Email: marketing@medicilon.com
Tel: +1(781)535-1428(U.S.)
Tel: 0044 7790 816 954 (Europe)
Tel: +82 70-8269-5849 (Korea)
Tel: +81 80-4421-6898 (Japan)
